Xininurad

Overview

Xininurad is a potent orally active URAT1 inhibitor with an IC 50 of 7.17 nM. Xininurad inhibits URAT1 activity to reduce serum uric acid levels and increase urinary uric acid excretion. Xininurad can be used for the research of hyperuricemia and gout.

Application

Products | Products > Disease Areas > Gout | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Purine Metabolism | Products > Disease Areas > Arthritis | Products > Disease Areas > Hyperuricemia | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > URAT1

Product Information

• Catalog No.: HY-147422
• CAS No.: 2365178-28-3
• Molecular Formula: C15H10Br2FN3O2
• Molecular Weight: 443.07
• Purity: 99.59%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (5.64 mM); Clear solution
• Availability: In-stock

Source

Original product source